Healthcare Finance News May 11, 2018
Strategies include increased competition and negotiation and incentives to lower list prices and out-of-pocket costs, HHS Sec. Alex Azar says.
President Donald Trump on Friday promised sweeping action to lower the price of prescription drugs.
Trump went after the middleman, without naming that entity, drug makers, insurers, pharmacy benefit managers, “everyone involved in the broken system.”
“The middle man became very, very rich,” Trump said. “They won’t be so rich anymore.
He also went after the drug lobby, which he said spent $280 million in a year. Health insurance companies and providers spent another $200 million to protect the status quo and keep prices artificially high, the president said.
But investors in the industry were reportedly relieved by the speech...
Today's Sponsors
Today's Sponsor